Any intervention to prevent violence (all interventions) showed no clear difference in number of low‐birthweight (< 2500 g) babies compared with standard care (low certainty).
Prophylactic intravenous antibiotics administered before cesarean… leads to lower maternal composite morbidity compared with after neonatal umbilical cord clamping (high certainty).
Prophylactic intravenous antibiotics administered before cesarean… leads to lower maternal endomyometritis compared with after neonatal umbilical cord clamping (high certainty).
Prophylactic intravenous antibiotics administered before cesarean… leads to lower maternal wound Infection compared with after neonatal umbilical cord clamping (high certainty).
Prophylactic intravenous antibiotics administered before cesarean… showed no clear difference in maternal UTI/cystitis/pyelonephritis compared with after neonatal umbilical cord clamping (moderate certainty).
Prophylactic intravenous antibiotics administered before cesarean… showed no clear difference in maternal respiratory infection (pneumonia) compared with after neonatal umbilical cord clamping (low certainty).
Prophylactic intravenous antibiotics administered before cesarean… showed no clear difference in neonatal sepsis compared with after neonatal umbilical cord clamping (moderate certainty).
Prophylactic intravenous antibiotics administered before cesarean… showed no clear difference in neonatal ICU admission compared with after neonatal umbilical cord clamping (high certainty).
Ambroxol showed no clear difference in incidence of RDS frequency in newborns compared with corticosteroid (betamethasone) (moderate certainty).
Ambroxol showed no clear difference in perinatal mortality frequency of deaths of newborns compared with corticosteroid (betamethasone) (moderate certainty).
It is very uncertain whether ambroxol changes adverse effects in pregnant women frequency in pregnant women compared with corticosteroid (betamethasone) (very low certainty).
Ambroxol showed no clear difference in incidence of RDS frequency in newborns compared with placebo or no treatment (low certainty).
Ambroxol showed no clear difference in perinatal mortality frequency of deaths of newborns compared with placebo or no treatment (low certainty).
Ambroxol showed no clear difference in adverse effects in pregnant women frequency in pregnant women compared with placebo or no treatment (low certainty).
Ambroxol showed no clear difference in other events in newborns ‐ Administration of pulmonary surfactant… compared with placebo or no treatment (low certainty).
Ambroxol showed no clear difference in other events in newborns ‐ Need for mechanical ventilation frequency… compared with placebo or no treatment (low certainty).
It is very uncertain whether the intervention changes manual removal of placenta Manual removal after intervention (very low certainty).
It is very uncertain whether the intervention changes severe postpartum haemorrhage Objectively or subjectively measured… (very low certainty).
It is very uncertain whether the intervention changes blood transfusion Blood transfusion during puerperium (very low certainty).